forgemax.FORGED. TESTED. PROVEN.
Test C 250mg/ml 10ml Vial by Rossiaz Lab
Purity Tested

Test C 250mg/ml 10ml Vial by Rossiaz Lab

Rossiaz Lab Test E 250mg/ml is a depot-injectable androgen — 250mg of Testosterone Enanthate per millilitre in a 10ml multi-dose vial — engineered to support structured anabolic cycles where a clearly defined post-cycle recovery window is part of the plan from day one. The enanthate ester produces a predictable multi-day washout curve, so users can calculate their SERM start date with precision rather than estimation. Each production lot is released only after passing HPLC content-uniformity verification and LAL bacterial endotoxin screening, with a traceable certificate issued per batch.

€38.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Maintains nitrogen balance and myofibrillar integrity throughout extended caloric deficits
  • 250mg/ml concentration delivers clean syringe measurements at common cutting-dose increments
  • Sustained depot release reduces injection frequency during high-training-volume cut phases
  • Purity Tested at lot level — HPLC assay confirms declared potency before distribution
  • Compatible with Primobolan and Oxandrolone for a low-aromatisation definition stack
  • LAL endotoxin-screened formulation supports parenteral safety across 10–14 week cycles
  • Batch-traceable Certificate of Analysis enables dose-consistency verification by the end user

Testosterone Cypionate in a Cutting Context: Why the Ester Choice Matters

Rossiaz Lab Test C 250mg/ml positions Testosterone Cypionate as the hormonal anchor of a caloric-deficit cycle — a role that demands serum stability over pulse amplitude. When training volume rises and calories fall, circulating testosterone suppression accelerates muscle catabolism; a weekly or twice-weekly cypionate depot directly counters this effect by maintaining androgen receptor occupancy throughout the diet. Compared to shorter esters such as propionate, the cypionate depot requires fewer injections across a 10–14 week cut, reducing injection-site stress during a period when recovery resources are already taxed by energy restriction.

Lean-Mass Preservation Protocols During Caloric Deficit

Testosterone Cypionate preserves nitrogen balance in skeletal muscle by upregulating protein synthesis genes during periods of negative energy intake. Research models document that androgen sufficiency during hypocaloric conditions reduces myofibrillar protein degradation by a measurable margin compared to hypogonadal states — the muscle-sparing effect is mechanistic, not incidental. At 250mg/ml, common cutting doses of 200–400mg per week translate to precise 0.8ml–1.6ml draws, eliminating ambiguity at the syringe. Rossiaz Lab's 10ml vial covers a full 10–14 week cutting phase from a single container when dosed at this range.

Purity Tested: Rossiaz Lab's Quality Infrastructure

Every batch of Rossiaz Lab Test C undergoes HPLC content assay to confirm that active testosterone concentration matches the declared 250mg/ml specification — a prerequisite for the dosing accuracy that cutting protocols demand. LAL endotoxin testing is applied at the individual lot level, confirming pyrogen-free parenteral safety before any vial enters the distribution chain. GMP-aligned batch controls govern compounding and sterile filtration, and the resulting Certificate of Analysis is batch-numbered to each vial, giving the end user full traceability. This documentation framework is particularly relevant during cutting cycles, where body-composition results depend on dose consistency rather than approximation.

Stacking Logic for Cutting Phases

Testosterone Cypionate at a base dose of 200–300mg per week pairs efficiently with non-aromatising compounds during a cut: Primobolan (Methenolone Enanthate) adds lean hardness through a separate androgen receptor pathway, while Anavar (Oxandrolone) raises the free-testosterone fraction by displacing sex hormone-binding globulin without contributing additional estrogenic load. Aromatase inhibitor titration remains essential — a lower weekly testosterone volume during a cut generally permits a reduced AI dose compared to an identical compound's bulking application, preventing over-suppression of estradiol that would negatively affect joint resilience during high-frequency training.

Usage

  1. Confirm your cutting-cycle goal — lean-mass preservation, recomposition, or pre-competition taper — and select the corresponding weekly dose from the dosage table above before drawing from the vial.
  2. Inspect the Rossiaz Lab vial for clarity and check the batch number against the Certificate of Analysis to verify Purity Tested status before the first injection of each new vial.
  3. Draw the calculated volume through a 21–23g needle to handle the oil viscosity; for cutting doses of 0.6–1.2ml a 3ml luer-lock syringe provides sufficient precision.
  4. Swap to a 25g or finer needle for glute or vastus lateralis injection; rotate sites systematically across the cycle to prevent localised fibrosis during a 10–14 week cut.
  5. Administer twice weekly (e.g. Monday and Thursday) to maintain more consistent serum androgen levels — particularly important during a caloric deficit when endogenous production is already blunted.
  6. Monitor serum estradiol and haematocrit at weeks 4 and 8; adjust aromatase inhibitor dosing in response to bloodwork rather than using a fixed AI protocol, as lower cutting doses typically require less AI support than bulking-equivalent doses.

Warnings

Contraindications: Not for use in individuals with prostate or breast carcinoma, severe hepatic impairment, untreated polycythaemia, or hypersensitivity to any component of the formulation. Women who are pregnant or planning pregnancy must not use this product.

Side Effects: Oestrogen-related effects including water retention, gynecomastia, and elevated blood pressure are possible and are managed with aromatase inhibitors; acne, accelerated androgenic alopecia, and injection-site discomfort may occur. HPG-axis suppression is universal and necessitates structured post-cycle recovery.

Monitoring: Obtain baseline bloodwork (serum testosterone, LH, FSH, haematocrit, lipid panel, liver enzymes, and estradiol) before cycle initiation. Retest at weeks 4 and 8; adjust AI dose based on serum estradiol results. Haematocrit elevation during a cutting cycle warrants immediate review, as dehydration can compound erythrocytosis risk.

PCT: Initiate SERM-based post-cycle therapy (Clomiphene or Tamoxifen) no earlier than 14 days after the final injection of Testosterone Cypionate to allow serum levels to decline adequately. PCT duration is typically 4–6 weeks; bloodwork at PCT completion guides the decision to extend or conclude recovery.

Frequently asked questions

Is Testosterone Cypionate an effective compound to include in a cutting cycle?
Yes — Testosterone Cypionate is highly effective in a cutting cycle as a lean-tissue preservation agent. Caloric deficits elevate cortisol and suppress endogenous androgens, accelerating muscle catabolism. Exogenous cypionate maintains androgen receptor occupancy throughout the diet, counteracting myofibrillar protein breakdown and allowing fat loss to proceed without proportional muscle loss.
What weekly dose of Rossiaz Lab Test C 250mg/ml is appropriate for a cutting phase?
A dose of 200–350mg per week is the practical cutting range for most users. At 250mg/ml, 200mg equals 0.8ml and 350mg equals 1.4ml — both measurable on a standard 2ml or 3ml syringe with precision. This range maintains androgen-driven muscle preservation without excessive aromatisation that would complicate estrogen management during a deficit.
Which compounds pair well with Testosterone Cypionate during a definition phase?
Non-aromatising injectables such as Methenolone Enanthate (Primobolan) and oral Oxandrolone (Anavar) are well-established partners. Primobolan adds lean mass and hardness through a distinct receptor-binding profile; Oxandrolone reduces SHBG, increasing bioactive free testosterone from the cypionate depot. Both choices keep total estrogenic load manageable — a critical consideration when cutting calories over 10–14 weeks.
Can I draw Rossiaz Lab Test C 250mg/ml into an insulin syringe for smaller cutting doses?
Yes, with the correct technique. Draw through a 21–23g needle to manage the oil viscosity of the vehicle, then switch to a 25–27g needle for the actual injection. At 250mg/ml, a 100mg cutting dose equals 0.4ml, which fits comfortably within a standard 1ml insulin syringe. Confirm the syringe is rated for oil-based solutions before use.
How should the Rossiaz Lab 10ml vial be stored after first opening during a long cutting cycle?
Store the opened vial at room temperature (15–25°C) away from direct light and heat. Refrigeration is not required and can increase oil viscosity, making draws more difficult. Discard the vial if the solution becomes cloudy, discoloured, or shows particulate matter. Record the opening date and inspect the rubber stopper for integrity before each draw across a 10–14 week cycle. (2) angle_used

Manufacturer

Rossiaz Lab's supply chain is structured around controlled distribution pathways that prioritise cold-chain integrity and documentation continuity from production release to end-user delivery. Each 10ml vial of Test C 250mg/ml leaves the facility with a batch-numbered Certificate of Analysis — covering HPLC content assay results and LAL endotoxin test outcomes — that travels with the shipment rather than existing only as an internal record. Distribution partners are selected under criteria that include storage-condition compliance and tamper-evident packaging preservation; vials arriving with compromised seals or without matching documentation are flagged for return under the brand's traceability protocol. This logistics architecture directly supports the GMP-aligned manufacturing controls applied upstream, ensuring that the potency and sterility confirmed at the point of production are not degraded before the product reaches the athlete.

Product details

BrandRossiaz Lab
Active ingredienttestosterone cypionate
Strength250 mg
FormVial
Pack size1 piece
Item numberINJ-TCYP-ROS-250-025

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Cipandrol 200mg/ml 10x1ml Ampoules by Balkan PharmaceuticalsEstablished Brand

Cipandrol 200mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

€38.00
Cypo-Testosterone 200mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Cypo-Testosterone 200mg/ml 10ml Vial by Beligas Pharmaceuticals

€38.00
Testacyp-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Testacyp-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€38.00
CypioTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

CypioTrex 350mg/ml 10ml Vial by Concentrex Labs

€38.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00